PCHSX Mutual Fund

PCHSX Mutual Fund

NAV$39.44
See how much of PCHSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$10M
Expense Ratio
1.79%
Dividend Yield (Current)
-
Holdings
47
Inception Date
Jul 26, 1999
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+11.39%
1 Year+19.97%
3 Year+12.77%
5 Year+6.14%
10 Year+6.60%

Asset Allocation

Stocks: 98.65%
Bonds: 0.30%
Cash: 1.05%
See how much of PCHSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.93%
JNJJohnson & Johnson - Common9.56%
ABBVAbbvie Inc.7.11%
UNHUnitedhealth Group Incorporated5.88%
MRKMerck & Company Inc5.86%
Top 10 Concentration: 60.10%Report Date: Sep 30, 2026
Download all 47 holdings for PCHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$5.45
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PCHSX Mutual Fund Overview

PCHSX Mutual Fund (Putnam Global Health Care Fund Class C) is managed by Putnam Investments with $9.9M in net assets. PCHSX expense ratio is 1.79%, holding 47 positions across sectors including Health Care, Financials. Inception date: 1999-07-26.

PCHSX performance shows a YTD return of 11.39%. The 1-year return is 19.97% and the 5-year return is 6.14%.

PCHSX top holdings include Eli Lilly & Co (12.9%), Johnson & Johnson - Common (9.6%), Abbvie Inc. (7.1%), Unitedhealth Group Incorporated (5.9%), Merck & Company Inc (5.9%). Go to all PCHSX holdings, PCHSX sectors, or PCHSX dividends.

PCHSX can be compared against other funds. Use PCHSX overlap to find shared positions, or PCHSX vs another fund for a side-by-side view. PCHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.